QUEBEC, July 29, 2012 - Icentia and the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) have agreed to collaborate for the testing of a unique electrocardiography monitoring solution for patients with suspected cardiac arrhythmia. This agreement will allow Icentia to benefit from IUCPQ's expertise during the device's development and will eventually lead to a clinical study to test efficacy.
For Icentia, involving such an important clinical partner at an early stage of a product development is a key element of its strategy. This approach ensures that healthcare institutions are provided with innovative, real-world solutions that are perfectly adapted to their requirements.
The IUCPQ is a leader in specialized and ultra-specialized care in cardiology. It is the healthcare center with the largest clinical volume in tertiary cardiology in Canada. IUCPQ's mission is to stop epidemic obesity and the progression of cardiac and pulmonary diseases. Learn more at http://www.iucpq.qc.ca.